MedPath

Validation Freestyle continuous registration of glucose for the purpose of safe and correct use in the Netherlands

Phase 4
Completed
Conditions
Diabetes
10018424
Registration Number
NL-OMON42315
Lead Sponsor
Interne geneeskunde
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Age 18-75 jaar
10 non-DM, 10 T1DM, 10 T2DM in a stable situation
Able to undergo the required controls and to fill in the questionnaires proposed
Able to perform general daily activities

Exclusion Criteria

Unable to understand the study information or the Dutch language
A condition that makes the health situation unstable or which results in the short term to serious deterioration or death.
Chrnisch gebruik van hoge doses paracetamol en / of vitamine C

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Validate the Abbott Freestyle-Libre glucose measurement technique used on<br /><br>verious insertion sites, by comparing its outcomes with another continuous<br /><br>glucose monitoring (CGM) technique and laboratory testing as the golden<br /><br>standard for glucose measurement.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. Comparing the use of the Freestyle Libre between insertion in the upper arm<br /><br>and abdominal insertion (currently the Freestyle Libre is only tested after<br /><br>insertion into the upper arm, comparative data on other places where this<br /><br>device can be inserted are missing)<br /><br>2. Study the glucose values after eating a meal using the Freestyle Libre and<br /><br>venous measurements (meal clamp technique)<br /><br>3. Study the influence of the use of paracetamol and vitamin C on the<br /><br>reliability of the Freestyle libre results.</p><br>
© Copyright 2025. All Rights Reserved by MedPath